SlideShare une entreprise Scribd logo
1  sur  8
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
1. PRODUCT AND COMPANY IDENTIFICATION 
Product name: DERMASOME TM- Res (NE) 
Product Number: DERM-2009 
Brand: DERMASOME TM 
Company Address: ENCAPSULA NANOSCIENCES LLC 
6 CADILLAC DRIVE SUITE 245 
BRENTWOOD, TN, 37027 
Technical Phone: 615-884-4442 
Fax: 615-250-8747 
Emergency Phone: 615-438-8553 
CHEMTREC: 1-800-424-9300 
2. COMPOSITION/INFORMATION ON INGREDIENTS 
Ingredient Name CAS# Percent 
WATER 7732-18-5 >90 
GLYCERIN 56-81-5 
1, 3 Butanediol 107-88-0 <5 
3,5,4-TRIHYHROXY-TRANS-STILBENE 501-36-0 
L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-47-5 <5 
3. HAZARDS IDENTIFCATION 
OSHA 
No known OSHA hazards 
TARGET ORGANS 
Skin, Respiratory, Eyes 
WHMIS HAZARD CLASS 
D1B toxic materials 
D2B toxic materials 
HMIS RATING 
HEALTH HAZARDS: 1 
FLAMMABILITY: 1 
CHRONIC HEALTH HAZARDS: * 
PHYSICAL HAZARDS: 0
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
NFPA RATING 
HEALTH HAZARD: 2 
FLAMMABILTY: 1 
REACTIVITY: 0 
POTENTIAL HEALTH EFFECTS 
Inhalation May be harmful if inhaled. 
Skin May be harmful if absorbed through skin 
Eyes May cause eye irritation. 
Ingestion May be harmful if swallowed 
Chronic No existing conditions have been investigated 
4. FIRST AID MEASURES 
ORAL EXPOSURE 
Do not induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with 
water. Consult a physician 
INHALATION EXPOSURE 
If inhaled, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give 
oxygen. Do not use mouth to mouth resuscitation. Consult a physician. 
DERMAL EXPOSURE 
In case of contact, immediately wash skin with soap and copious amounts of water. Cover skin with 
an emollient. Contact a physician. 
EYE EXPOSURE 
In case of contact, check or remove any contact lenses; immediately flush eyes with copious amounts 
of water for at least 15 minutes. Contact a physician. 
5. FIRE FIGHTING MEASURES 
FLAMMABILITY 
Not available 
EXTINGUISHING MEDIA 
It is suitable to use water spray, alcohol -resistant foam, dry chemical or carbon dioxide.
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
SPECIAL PROCTECTIVE EQUIPMENT FOR FIRE-FIGHTERS 
Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and 
eyes. Included a positive pressure NIOSH approved self-contained breathing apparatus. 
HAZARDOUS COMBUSTION PRODUCTS 
Carbon oxides 
SPECIAL REMARKS 
Not available 
6. ACCIDENTAL RELEASE MEASURES 
METHODS FOR CLEANING UP 
Soak up inert absorbent material and dispose of as waste. Keep in suitable container for disposal. 
Use appropriate tools to put this spilled solid in a convenient waste disposable container and finish 
cleaning by spreading water on the contaminated surface and dispose of according to local and 
region authority requirements. Allow to evacuate through the sanitary system 
ENVIRONMENTAL PRECAUTIONS 
Do not let product enter drains. If safe to do so prevent further leakages or spills. 
PERSONAL PRECAUTIONS 
Use personal protective equipment. Avoid breathing in vapors, mist or gas. Ensure adequate 
ventilation. Prepare evacuation sites. 
7. HANDLING AND STORAGE 
HANDLING 
User Exposure: Do not breathe vapor, dust, fume, gas, mist and spray. Avoid prolonged or repeated 
exposure. Do not get in eyes, on skin, on clothing. Wash hands thoroughly after handling. 
STORAGE 
Suitable: Keep tightly container closed. Store in temperature between approximately 2-8 o C. Do not 
freeze keep in refrigerator. Product is sensitive to moisture and light. Keep product and empty 
container away from heat and sources ignition. 
8. EXPOSURE CONTROLS/ PERSONAL PROTECTION 
ENGINEERING CONTROLS 
Safety shower and eye bath. Mechanical exhaust required. 
PERSONAL PROTECTIVE EQUIPMENT 
Respiratory: Use respirators and components tested and approved under appropriate government 
standards such as NIOSH (US) in accord with 29 CFR 1910.134 or EN 149, use either an atmosphere 
supply respirator or air purifying respirator. Also follow face protection regulations in 29 CFR 
1910.133 or European standard EN 166. Also use a full -face respirator with multi -purpose
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
combination (US) or type ABEK (EN 14387) respirator cartridges as a back up to engineering 
controls. If the respirator is the sole means of protection, use a full -face supplied airs respirator. 
Use respirators and components tested and approved under appropriate government standers 
such as NIOSH (US) or CEN (EU). 
Hand: Compatible chemical -resistant gloves. 
Eye: Chemical safety goggles. Safety glasses with side-shields conforming to EN 166 use equipment 
for eye protection listed and approved under appropriated government standards such as NIOSH 
(US) or EN166 (EU) 
Skin and Body: Wear a complete suit protecting against chemicals. 
GENERAL HYGIENE MEASURES 
Wash hands thoroughly after handling. Wash contaminated clothing before reuse. Prepare all 
materials under the fume hood and avoid generating aerosols. 
9. PHYSICAL AND CHEMICAL PROPERTIES 
Appearance 
white, viscous liquid 
Safety data 
N/A 
Melting point 
N/A 
Boiling point 
N/A 
Flash point 
N/A 
Ignition Temperature 
N/A 
Lower explosion limit 
N/A 
Upper Explosion limit 
N/A 
Water Solubility 
N/A 
Density 
N/A 
10. STABILITY AND REACITIVITY 
STORAGE STABILITY 
Store under recommended conditions .
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
MATERIALS TO AVIOD 
Strong oxidizing agents, strong acids 
HAZARDOUS DECOMPOSITION PRODUCTS 
N/A 
CONDITIONS TO AVOID 
Light and exposure to moisture. Strong bases and Strong oxidizing agents . 
11. TOXICOLOGICAL INFORMATION 
CARCINOGENICITY 
This product contains a component that has been reported to be carcinogenic based on its IARC, OHSA, ACGIH, 
NTP, or EPA classification. 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the IARC. 
OHSA: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the OHSA. 
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the ACGIH. 
EPA: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the EPA. 
CHRONIC. 
Only select Reregister or Toxic of Chemical Substances (RTECS) data as presented here. See 
actual entry RTECS for complete information. Product is harmful by ingestion. 
Repeated contact may cause allergic reactions in very susceptible persons. 
ACUTE TOXICITY 
1,3-Butanediol : Oral LD50- mouse rat-698 mg/kg 
Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) 
Dermal LD50- rabbit >20,000 mg/kg 
Glycerin: Oral LD50- mouse rat-698 mg/kg 
Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) 
Dermal LD50- rabbit >20,000 mg/kg 
ADDITIONAL INFORMATION 
Prolonged or repeated exposure may result in Nausea, Headache, or Vomiting 
Kidney- irregularities-based on Human evidence
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
ROUTE OF EXPOSURE 
Skin Contact: May cause skin irritation. May produce an allergic reaction. 
Skin Absorption: May be harmful if absorbed through the skin 
Eye Contact: May Cause eye irritation and risk serious damage 
Inhalation: Materials may be irritating to mucous membranes and upper respira tory tract. 
Ingestion: May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea, 
vomiting and diarrhea. 
SIGNS AND SYMPTOMS OF EXPOSURE 
Symptoms have not be thoroughly investigated 
12. ECOLOGICAL INFORMATION 
Elimination information (persistence and degradability) 
N/A 
Ecotoxicity effects 
N/A 
Further information on ecology 
N/A 
13. DISPOSAL CONSIDERATIONS 
PRODUCT 
Observe all federal, state, and local environment regulations. Contact a licensed professional waste 
disposal service to remove this material 
CONTAMINATED PACKAGING 
Observe all federal, state, and local environment regulations. 
14. TRANSPROT INFORMATION 
DOT (US) 
Not dangerous goods 
IMDG 
Not dangerous goods 
IATA 
Not dangerous goods
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
15. REGULATORY INFORMATION 
OSHA HAZARDS 
OSHA: Hazardous by definition of Hazard Communication Standard (29 SFR 1910.1200). EINECS: 
this product is on the European Inventory of Existing Commercial Chemical Substances 
SARA 302 COMPONENTS 
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title 
III, Section 302 
SARA 313 COMPONENTS 
SARA 313: This material does not contain any chemical components with known CAS numbers 
that exceed threshold (De Minimis) reporting levels establi shed be SARA Title III, Section 313 
SARA 311/312 HAZARDS 
Acute health hazards, chronic health hazards , fire hazard 
MASSACHUSETTS RIGHT TO KNOW COMPONENTS 
CAS-No. Revision Date 
Glycerol 56-81-5 2007-03-01 
PENNSYVANIA RIGHT TO KNOW COMPONENTS 
CAS-No. Revision Date 
L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-48-6 1989-08-11 
Glycerol 56-81-5 2007-03-01 
Butane-1,3-diol 107-88-0 
Water 7732-18-5 
Resveratrol 501-36-0 
NEW JERSEY RIGHT TO KNOW COMPONENTS 
CAS-No. Revision Date 
L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-48-6 1989-08-11 
Glycerol 56-81-5 2007-03-01 
Butane-1,3-diol 107-88-0 
Water 7732-18-5 
Resveratrol 501-36-0 
CALIFORNIA PROP. 65 COMPONENTS 
CAS-No. Revision Date 
L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-48-6 1989-08-11 
U.S Department of Homeland Security 
This product does not contain any DHS chemicals
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
Canada 
This product has been classified in accordance with the hazard criteria of the Controlled Products 
Regulation (CPR) and the MSDS contains all the information required by the CPR. 
CAS# 7732185 is listed on Canada's DSL List 
TSCA 
CAS# 7732185 is listed on the TSCA Inventory 
16. OTHER INFORMATION 
Copyright 2013 Encapsula NanoSciences LLC license granted to make unlimited paper copies for internal 
use only. 
The above information is believed to be correct but does not support to be all inclusive and shall be used 
only as a guide. The information in this document is based on the present state of our knowledge and is 
applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Encapsula NanoSciences LLC shall not be held liable for any 
damage resulting from handling or from contact with the above product.

Contenu connexe

Tendances

Tendances (20)

MSDS DermaMix-Chol
MSDS DermaMix-Chol MSDS DermaMix-Chol
MSDS DermaMix-Chol
 
MSDS Dermasome-ACE (NE, not containing ethanol)
MSDS Dermasome-ACE (NE, not containing ethanol)MSDS Dermasome-ACE (NE, not containing ethanol)
MSDS Dermasome-ACE (NE, not containing ethanol)
 
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
 
MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)
 
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
 
MSDS Cosmesome-ACE (NE, not containing ethanol)
MSDS Cosmesome-ACE (NE, not containing ethanol)MSDS Cosmesome-ACE (NE, not containing ethanol)
MSDS Cosmesome-ACE (NE, not containing ethanol)
 
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
 
MSDS Dermasome Conatining Alcohol
MSDS Dermasome Conatining Alcohol MSDS Dermasome Conatining Alcohol
MSDS Dermasome Conatining Alcohol
 
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
 
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
 
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
 
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
 
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
 
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
 
MSDS for PEGylated liposomal Doxorubicin_Doxosome
MSDS for PEGylated liposomal Doxorubicin_DoxosomeMSDS for PEGylated liposomal Doxorubicin_Doxosome
MSDS for PEGylated liposomal Doxorubicin_Doxosome
 
MSDS Cosmesome-Ubq Containing Alcohol
MSDS Cosmesome-Ubq Containing AlcoholMSDS Cosmesome-Ubq Containing Alcohol
MSDS Cosmesome-Ubq Containing Alcohol
 
MSDS Cosmesome (NE, Not containing ethanol)
MSDS Cosmesome (NE, Not containing ethanol)MSDS Cosmesome (NE, Not containing ethanol)
MSDS Cosmesome (NE, Not containing ethanol)
 
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
 
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
 
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
 

En vedette

Managed Futures
Managed FuturesManaged Futures
Managed Futures
bzinchenko
 
Building con 1 (arc 1523) project 1 brief aug 2014
Building con 1 (arc 1523) project 1 brief aug 2014Building con 1 (arc 1523) project 1 brief aug 2014
Building con 1 (arc 1523) project 1 brief aug 2014
Anthony Chew
 
Kearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggis
Kearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggisKearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggis
Kearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggis
marlinasitipriyati
 

En vedette (20)

Managed Futures - Chaos Cruncher
Managed Futures - Chaos CruncherManaged Futures - Chaos Cruncher
Managed Futures - Chaos Cruncher
 
8 Decemeber 2014 CCAFS Side Event COP 20 Manyewu Mutamba
8 Decemeber 2014 CCAFS Side Event COP 20  Manyewu Mutamba8 Decemeber 2014 CCAFS Side Event COP 20  Manyewu Mutamba
8 Decemeber 2014 CCAFS Side Event COP 20 Manyewu Mutamba
 
Liquid crystal bio-based epoxy coating with enhanced performance
Liquid crystal bio-based epoxy coating with enhanced performanceLiquid crystal bio-based epoxy coating with enhanced performance
Liquid crystal bio-based epoxy coating with enhanced performance
 
KARAKTERISTIK GENERASI IBRAHIM
KARAKTERISTIK GENERASI IBRAHIMKARAKTERISTIK GENERASI IBRAHIM
KARAKTERISTIK GENERASI IBRAHIM
 
Sinterklaas
SinterklaasSinterklaas
Sinterklaas
 
Managed Futures
Managed FuturesManaged Futures
Managed Futures
 
Mitigation of the Harmonics under Reactive Power Compensation by SHPF-TCR Usi...
Mitigation of the Harmonics under Reactive Power Compensation by SHPF-TCR Usi...Mitigation of the Harmonics under Reactive Power Compensation by SHPF-TCR Usi...
Mitigation of the Harmonics under Reactive Power Compensation by SHPF-TCR Usi...
 
Analysis on Recommended System for Web Information Retrieval Using HMM
Analysis on Recommended System for Web Information Retrieval Using HMMAnalysis on Recommended System for Web Information Retrieval Using HMM
Analysis on Recommended System for Web Information Retrieval Using HMM
 
Building con 1 (arc 1523) project 1 brief aug 2014
Building con 1 (arc 1523) project 1 brief aug 2014Building con 1 (arc 1523) project 1 brief aug 2014
Building con 1 (arc 1523) project 1 brief aug 2014
 
Infografia. LECXIT. 10 claus LECXIT. Presentació de resultats
Infografia. LECXIT. 10 claus LECXIT. Presentació de resultatsInfografia. LECXIT. 10 claus LECXIT. Presentació de resultats
Infografia. LECXIT. 10 claus LECXIT. Presentació de resultats
 
Kearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggis
Kearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggisKearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggis
Kearifan Lokal tentang Pencemaran limbah di Sungai perkampungan pondok manggis
 
Bai tap lon 1
Bai tap lon 1Bai tap lon 1
Bai tap lon 1
 
Increment of carbohydrate concentration of Chlorella minutissima microalgae f...
Increment of carbohydrate concentration of Chlorella minutissima microalgae f...Increment of carbohydrate concentration of Chlorella minutissima microalgae f...
Increment of carbohydrate concentration of Chlorella minutissima microalgae f...
 
Presenting Activity Flow Process
Presenting Activity Flow ProcessPresenting Activity Flow Process
Presenting Activity Flow Process
 
Измерение радиационного гамма- фона в здании колледжа г. Новозыбкова
Измерение  радиационного гамма- фона в здании  колледжа г. НовозыбковаИзмерение  радиационного гамма- фона в здании  колледжа г. Новозыбкова
Измерение радиационного гамма- фона в здании колледжа г. Новозыбкова
 
παραμυθι
παραμυθιπαραμυθι
παραμυθι
 
483 2001 zz_v20160101
483 2001 zz_v20160101483 2001 zz_v20160101
483 2001 zz_v20160101
 
полногеномный скрининг эмбрионов методом A cgh
полногеномный скрининг эмбрионов методом A cghполногеномный скрининг эмбрионов методом A cgh
полногеномный скрининг эмбрионов методом A cgh
 
Sholat
SholatSholat
Sholat
 
συμη Powerpoint
συμη Powerpointσυμη Powerpoint
συμη Powerpoint
 

Similaire à MSDS Dermasome-Res (NE, not containing ethanol)

Similaire à MSDS Dermasome-Res (NE, not containing ethanol) (14)

MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)
 
MSDS Cosmesome-Res Containing Alcohol
MSDS Cosmesome-Res Containing Alcohol MSDS Cosmesome-Res Containing Alcohol
MSDS Cosmesome-Res Containing Alcohol
 
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
 
MSDS Cosmesome Containing Alcohol
MSDS Cosmesome Containing AlcoholMSDS Cosmesome Containing Alcohol
MSDS Cosmesome Containing Alcohol
 
MSDS Dermasome-Ubq Containing Alcohol
MSDS Dermasome-Ubq Containing AlcoholMSDS Dermasome-Ubq Containing Alcohol
MSDS Dermasome-Ubq Containing Alcohol
 
MSDS Cosmesome-Chol Containing Alcohol
MSDS Cosmesome-Chol Containing AlcoholMSDS Cosmesome-Chol Containing Alcohol
MSDS Cosmesome-Chol Containing Alcohol
 
MSDS Dermasome-Res Containing Alcohol
MSDS Dermasome-Res Containing AlcoholMSDS Dermasome-Res Containing Alcohol
MSDS Dermasome-Res Containing Alcohol
 
MSDS Dermasome-Chol Containing Alcohol
MSDS Dermasome-Chol Containing Alcohol MSDS Dermasome-Chol Containing Alcohol
MSDS Dermasome-Chol Containing Alcohol
 
MSDS CosmoMix-ACE
MSDS CosmoMix-ACE MSDS CosmoMix-ACE
MSDS CosmoMix-ACE
 
MSDS for Non-PEGylated liposomes containing Caproylamine lipid for conjugatio...
MSDS for Non-PEGylated liposomes containing Caproylamine lipid for conjugatio...MSDS for Non-PEGylated liposomes containing Caproylamine lipid for conjugatio...
MSDS for Non-PEGylated liposomes containing Caproylamine lipid for conjugatio...
 
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
 
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
 
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
 
MSDS for Non-PEGylated liposomes containing Dodecanyl lipid for conjugation_I...
MSDS for Non-PEGylated liposomes containing Dodecanyl lipid for conjugation_I...MSDS for Non-PEGylated liposomes containing Dodecanyl lipid for conjugation_I...
MSDS for Non-PEGylated liposomes containing Dodecanyl lipid for conjugation_I...
 

Plus de Encapsula NanoSciences

Product Spec Sheet Spec sheets cosmesome
Product Spec Sheet Spec sheets cosmesomeProduct Spec Sheet Spec sheets cosmesome
Product Spec Sheet Spec sheets cosmesome
Encapsula NanoSciences
 

Plus de Encapsula NanoSciences (13)

SDS for Clodrosome® by Encapsula NanoSciences
SDS for Clodrosome® by Encapsula NanoSciencesSDS for Clodrosome® by Encapsula NanoSciences
SDS for Clodrosome® by Encapsula NanoSciences
 
Product Spec Sheet DermaMix-ACE
Product Spec Sheet DermaMix-ACEProduct Spec Sheet DermaMix-ACE
Product Spec Sheet DermaMix-ACE
 
Product Spec Sheet DermaMix-Ubq
Product Spec Sheet DermaMix-UbqProduct Spec Sheet DermaMix-Ubq
Product Spec Sheet DermaMix-Ubq
 
Product Spec Sheet DermaMix-Res
Product Spec Sheet DermaMix-ResProduct Spec Sheet DermaMix-Res
Product Spec Sheet DermaMix-Res
 
Product Spec Sheet DermaMix-Chol
Product Spec Sheet DermaMix-CholProduct Spec Sheet DermaMix-Chol
Product Spec Sheet DermaMix-Chol
 
Spec sheets derma mix - ace
Spec sheets derma mix - aceSpec sheets derma mix - ace
Spec sheets derma mix - ace
 
Product Spec Sheet CosmoMix-Ubq
Product Spec Sheet CosmoMix-UbqProduct Spec Sheet CosmoMix-Ubq
Product Spec Sheet CosmoMix-Ubq
 
Product Spec Sheet CosmoMix-Res
Product Spec Sheet CosmoMix-ResProduct Spec Sheet CosmoMix-Res
Product Spec Sheet CosmoMix-Res
 
Product Spec Sheet CosmoMix-Chol
Product Spec Sheet CosmoMix-CholProduct Spec Sheet CosmoMix-Chol
Product Spec Sheet CosmoMix-Chol
 
Product Spec Sheet CosmoMix-ACE
Product Spec Sheet CosmoMix-ACEProduct Spec Sheet CosmoMix-ACE
Product Spec Sheet CosmoMix-ACE
 
Product Spec Sheet Spec sheets cosmesome
Product Spec Sheet Spec sheets cosmesomeProduct Spec Sheet Spec sheets cosmesome
Product Spec Sheet Spec sheets cosmesome
 
MSDS DermaMix-ACE
MSDS DermaMix-ACEMSDS DermaMix-ACE
MSDS DermaMix-ACE
 
MSDS Dermasome-ACE Containing Alcohol
MSDS Dermasome-ACE Containing Alcohol MSDS Dermasome-ACE Containing Alcohol
MSDS Dermasome-ACE Containing Alcohol
 

Dernier

Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
MohamedFarag457087
 
POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.
Silpa
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
Silpa
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
NazaninKarimi6
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
levieagacer
 

Dernier (20)

Genetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditionsGenetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditions
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
 
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsTransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
 
Genome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxGenome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptx
 
POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.
 
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIACURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
 
Chemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdfChemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdf
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.
 
Site Acceptance Test .
Site Acceptance Test                    .Site Acceptance Test                    .
Site Acceptance Test .
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
 
Gwalior ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Gwalior ESCORT SERVICE❤CALL GIRL
Gwalior ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Gwalior ESCORT SERVICE❤CALL GIRLGwalior ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Gwalior ESCORT SERVICE❤CALL GIRL
Gwalior ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Gwalior ESCORT SERVICE❤CALL GIRL
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
 
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptx
 
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICEPATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
 
Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.
 
GBSN - Microbiology (Unit 3)Defense Mechanism of the body
GBSN - Microbiology (Unit 3)Defense Mechanism of the body GBSN - Microbiology (Unit 3)Defense Mechanism of the body
GBSN - Microbiology (Unit 3)Defense Mechanism of the body
 

MSDS Dermasome-Res (NE, not containing ethanol)

  • 1. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 1. PRODUCT AND COMPANY IDENTIFICATION Product name: DERMASOME TM- Res (NE) Product Number: DERM-2009 Brand: DERMASOME TM Company Address: ENCAPSULA NANOSCIENCES LLC 6 CADILLAC DRIVE SUITE 245 BRENTWOOD, TN, 37027 Technical Phone: 615-884-4442 Fax: 615-250-8747 Emergency Phone: 615-438-8553 CHEMTREC: 1-800-424-9300 2. COMPOSITION/INFORMATION ON INGREDIENTS Ingredient Name CAS# Percent WATER 7732-18-5 >90 GLYCERIN 56-81-5 1, 3 Butanediol 107-88-0 <5 3,5,4-TRIHYHROXY-TRANS-STILBENE 501-36-0 L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-47-5 <5 3. HAZARDS IDENTIFCATION OSHA No known OSHA hazards TARGET ORGANS Skin, Respiratory, Eyes WHMIS HAZARD CLASS D1B toxic materials D2B toxic materials HMIS RATING HEALTH HAZARDS: 1 FLAMMABILITY: 1 CHRONIC HEALTH HAZARDS: * PHYSICAL HAZARDS: 0
  • 2. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 NFPA RATING HEALTH HAZARD: 2 FLAMMABILTY: 1 REACTIVITY: 0 POTENTIAL HEALTH EFFECTS Inhalation May be harmful if inhaled. Skin May be harmful if absorbed through skin Eyes May cause eye irritation. Ingestion May be harmful if swallowed Chronic No existing conditions have been investigated 4. FIRST AID MEASURES ORAL EXPOSURE Do not induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician INHALATION EXPOSURE If inhaled, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give oxygen. Do not use mouth to mouth resuscitation. Consult a physician. DERMAL EXPOSURE In case of contact, immediately wash skin with soap and copious amounts of water. Cover skin with an emollient. Contact a physician. EYE EXPOSURE In case of contact, check or remove any contact lenses; immediately flush eyes with copious amounts of water for at least 15 minutes. Contact a physician. 5. FIRE FIGHTING MEASURES FLAMMABILITY Not available EXTINGUISHING MEDIA It is suitable to use water spray, alcohol -resistant foam, dry chemical or carbon dioxide.
  • 3. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 SPECIAL PROCTECTIVE EQUIPMENT FOR FIRE-FIGHTERS Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes. Included a positive pressure NIOSH approved self-contained breathing apparatus. HAZARDOUS COMBUSTION PRODUCTS Carbon oxides SPECIAL REMARKS Not available 6. ACCIDENTAL RELEASE MEASURES METHODS FOR CLEANING UP Soak up inert absorbent material and dispose of as waste. Keep in suitable container for disposal. Use appropriate tools to put this spilled solid in a convenient waste disposable container and finish cleaning by spreading water on the contaminated surface and dispose of according to local and region authority requirements. Allow to evacuate through the sanitary system ENVIRONMENTAL PRECAUTIONS Do not let product enter drains. If safe to do so prevent further leakages or spills. PERSONAL PRECAUTIONS Use personal protective equipment. Avoid breathing in vapors, mist or gas. Ensure adequate ventilation. Prepare evacuation sites. 7. HANDLING AND STORAGE HANDLING User Exposure: Do not breathe vapor, dust, fume, gas, mist and spray. Avoid prolonged or repeated exposure. Do not get in eyes, on skin, on clothing. Wash hands thoroughly after handling. STORAGE Suitable: Keep tightly container closed. Store in temperature between approximately 2-8 o C. Do not freeze keep in refrigerator. Product is sensitive to moisture and light. Keep product and empty container away from heat and sources ignition. 8. EXPOSURE CONTROLS/ PERSONAL PROTECTION ENGINEERING CONTROLS Safety shower and eye bath. Mechanical exhaust required. PERSONAL PROTECTIVE EQUIPMENT Respiratory: Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) in accord with 29 CFR 1910.134 or EN 149, use either an atmosphere supply respirator or air purifying respirator. Also follow face protection regulations in 29 CFR 1910.133 or European standard EN 166. Also use a full -face respirator with multi -purpose
  • 4. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 combination (US) or type ABEK (EN 14387) respirator cartridges as a back up to engineering controls. If the respirator is the sole means of protection, use a full -face supplied airs respirator. Use respirators and components tested and approved under appropriate government standers such as NIOSH (US) or CEN (EU). Hand: Compatible chemical -resistant gloves. Eye: Chemical safety goggles. Safety glasses with side-shields conforming to EN 166 use equipment for eye protection listed and approved under appropriated government standards such as NIOSH (US) or EN166 (EU) Skin and Body: Wear a complete suit protecting against chemicals. GENERAL HYGIENE MEASURES Wash hands thoroughly after handling. Wash contaminated clothing before reuse. Prepare all materials under the fume hood and avoid generating aerosols. 9. PHYSICAL AND CHEMICAL PROPERTIES Appearance white, viscous liquid Safety data N/A Melting point N/A Boiling point N/A Flash point N/A Ignition Temperature N/A Lower explosion limit N/A Upper Explosion limit N/A Water Solubility N/A Density N/A 10. STABILITY AND REACITIVITY STORAGE STABILITY Store under recommended conditions .
  • 5. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 MATERIALS TO AVIOD Strong oxidizing agents, strong acids HAZARDOUS DECOMPOSITION PRODUCTS N/A CONDITIONS TO AVOID Light and exposure to moisture. Strong bases and Strong oxidizing agents . 11. TOXICOLOGICAL INFORMATION CARCINOGENICITY This product contains a component that has been reported to be carcinogenic based on its IARC, OHSA, ACGIH, NTP, or EPA classification. IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the IARC. OHSA: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the OHSA. ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the ACGIH. EPA: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the EPA. CHRONIC. Only select Reregister or Toxic of Chemical Substances (RTECS) data as presented here. See actual entry RTECS for complete information. Product is harmful by ingestion. Repeated contact may cause allergic reactions in very susceptible persons. ACUTE TOXICITY 1,3-Butanediol : Oral LD50- mouse rat-698 mg/kg Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) Dermal LD50- rabbit >20,000 mg/kg Glycerin: Oral LD50- mouse rat-698 mg/kg Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) Dermal LD50- rabbit >20,000 mg/kg ADDITIONAL INFORMATION Prolonged or repeated exposure may result in Nausea, Headache, or Vomiting Kidney- irregularities-based on Human evidence
  • 6. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 ROUTE OF EXPOSURE Skin Contact: May cause skin irritation. May produce an allergic reaction. Skin Absorption: May be harmful if absorbed through the skin Eye Contact: May Cause eye irritation and risk serious damage Inhalation: Materials may be irritating to mucous membranes and upper respira tory tract. Ingestion: May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhea. SIGNS AND SYMPTOMS OF EXPOSURE Symptoms have not be thoroughly investigated 12. ECOLOGICAL INFORMATION Elimination information (persistence and degradability) N/A Ecotoxicity effects N/A Further information on ecology N/A 13. DISPOSAL CONSIDERATIONS PRODUCT Observe all federal, state, and local environment regulations. Contact a licensed professional waste disposal service to remove this material CONTAMINATED PACKAGING Observe all federal, state, and local environment regulations. 14. TRANSPROT INFORMATION DOT (US) Not dangerous goods IMDG Not dangerous goods IATA Not dangerous goods
  • 7. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 15. REGULATORY INFORMATION OSHA HAZARDS OSHA: Hazardous by definition of Hazard Communication Standard (29 SFR 1910.1200). EINECS: this product is on the European Inventory of Existing Commercial Chemical Substances SARA 302 COMPONENTS SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302 SARA 313 COMPONENTS SARA 313: This material does not contain any chemical components with known CAS numbers that exceed threshold (De Minimis) reporting levels establi shed be SARA Title III, Section 313 SARA 311/312 HAZARDS Acute health hazards, chronic health hazards , fire hazard MASSACHUSETTS RIGHT TO KNOW COMPONENTS CAS-No. Revision Date Glycerol 56-81-5 2007-03-01 PENNSYVANIA RIGHT TO KNOW COMPONENTS CAS-No. Revision Date L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-48-6 1989-08-11 Glycerol 56-81-5 2007-03-01 Butane-1,3-diol 107-88-0 Water 7732-18-5 Resveratrol 501-36-0 NEW JERSEY RIGHT TO KNOW COMPONENTS CAS-No. Revision Date L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-48-6 1989-08-11 Glycerol 56-81-5 2007-03-01 Butane-1,3-diol 107-88-0 Water 7732-18-5 Resveratrol 501-36-0 CALIFORNIA PROP. 65 COMPONENTS CAS-No. Revision Date L-α-PHOSPHATIDYLCHOLINE, (95%) 97281-48-6 1989-08-11 U.S Department of Homeland Security This product does not contain any DHS chemicals
  • 8. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 Canada This product has been classified in accordance with the hazard criteria of the Controlled Products Regulation (CPR) and the MSDS contains all the information required by the CPR. CAS# 7732185 is listed on Canada's DSL List TSCA CAS# 7732185 is listed on the TSCA Inventory 16. OTHER INFORMATION Copyright 2013 Encapsula NanoSciences LLC license granted to make unlimited paper copies for internal use only. The above information is believed to be correct but does not support to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Encapsula NanoSciences LLC shall not be held liable for any damage resulting from handling or from contact with the above product.